EBOS welcomes finalisation of First PWA

20 December 2024

NZX/ASX Code: EBO

EBOS welcomes the finalisation of the First Pharmaceutical Wholesaler
Agreement


EBOS Group Limited (“EBOS”) advises that the First Pharmaceutical Wholesaler Agreement (the
“Wholesaler Agreement”) has been signed by the Australian Government and the pharmaceutical
wholesaler industry body, the National Pharmaceutical Services Association (NPSA).

The Wholesaler Agreement outlines the Australian Government’s funding for wholesalers that are
part of the Community Service Obligation (“CSO”) until 31 December 2029 and operates alongside
the 8
th
Community Pharmacy Agreement (“8
th
CPA”), which was executed between the Australian
Government and the Pharmacy Guild on 3 June 2024.

EBOS would like to thank the Department of Health and Aged Care and the Federal Minister for
Health and Aged Care, The Honourable Mark Butler MP, for their constructive engagement during
negotiations and for acknowledging the role EBOS plays as part of Australia’s health system.

The Wholesaler Agreement provides for a modest funding increase from FY25 and a further increase
from FY27. These changes address significant erosion of supply chain funding and mean that
Australians will continue to receive the uninterrupted medicine distribution service they have come
to rely on. EBOS reiterates its guidance for FY25 that the Group expects to generate Underlying
EBITDA
1
of between $575m to $600m.




For further information please contact:
Martin Krauskopf
Executive General Manager, Strategy and Mergers & Acquisitions
+61 3 9918 5555
Martin.Krauskopf@ebosgroup.com

Authorised for lodgement with NZX and ASX by Janelle Cain, General Counsel, EBOS Group Limited.



About EBOS Group
EBOS Group Limited NZBN 9429031998840 (NZX/ASX Code: EBO) is the largest and most diversified
Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical
products. It is also a leading Australasian animal care brand owner, product marketer and distributor.

1
Underlying EBITDA excludes amounts that are considered one off or non-recurring items.